The DOI matches its Crossref record.
A superfamily of conserved domains in DNA damage‐ responsive cell cycle checkpoint proteins
Open accessAbstract
Computer analysis of a conserved domain, BRCT, first described at the carboxyl ter‐minus of the breast cancer protein BRCA1, a p53 binding protein (53BP1), and the yeast cell cycle checkpoint protein RAD9 revealed a large super‐ family of domains that occur predominantly in proteins involved in cell cycle checkpoint functions responsive to DNA damage. The BRCT domain consists of ~95 amino acid residues and occurs as a tandem repeat at the carboxyl terminus of numerous proteins, but has been observed also as a tandem repeat at the amino terminus or as a single copy. The BRCT superfamily presently includes ~40 nonorthologous proteins, namely, BRCA1, 53BP1, and RAD9; a protein family that consists of the fission yeast replication checkpoint protein Rad4, the oncoprotein ECT2, the DNA repair protein XRCC1, and yeast DNA polymerase subunit DPB11; DNA binding enzymes such as terminal deoxynucleotidyltransferases, deoxycy‐ tidyl transferase involved in DNA repair, and DNA‐ligases III and IV; yeast multifunctional transcription factor RAP1; and several uncharacterized gene products. Another previously described domain that is shared by bacterial NAD‐dependent DNA‐ligases, the large subunits of eukaryotic replication factor C, and poly(ADP‐ri‐ bose) polymerases appears to be a distinct version of the BRCT domain. The retinoblastoma protein (a universal tumor suppressor) and related proteins may contain a distant relative of the BRCT domain. Despite the functional diversity of all these proteins, participation in DNA damage‐re‐ sponsive checkpoints appears to be a unifying theme. Thus, the BRCT domain is likely to perform critical, yet uncharacterized, functions in the cell cycle control of organisms from bacteria to humans. The car boxyterminal BRCT domain of BRCA1 corresponds precisely to the recently identified minimal transcription activation domain of this protein, indicating one such function.— Bork, P., Hofmann, K., Bucher, P., Neuwald, A. F., Altschul, S. F., Koonin, E. V. A superfamily of conserved domains in DNA damage‐responsive cell cycle checkpoint proteins. FASEB J. 11, 68‐ 76 (1997)
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“These findings, together with the high conservation of the BRCA1-BRCT domain throughout evolution [35], suggested that the BRCT domain was essential for the tumor-suppressing function of BRCA1.”
From Hereditary Breast Cancer and the BRCA1-Associated FANCJ/BACH1/BRIP1 (2011) · cites this paper as [35]
Citations
Cited by
Sorted by citations
Items 701–749 of 749
Identifying Dynamic Protein Complexes
Srihari, S., Yong, C. H., & Wong, L. (2017) · doi:10.1145/3064650.3064657
Samuel, N. (2012) · TSpace (University of Toronto)
Physical and Chemical Properties of DNA Ligases
Abdolahi, S., Borhani‐Haghighi, M., & Aligholi, H. (2017) · The Neuroscience Journal of Shefaye Khatam · doi:10.18869/acadpub.shefa.5.2.s1.40
Novel Approaches to Studying BRCA Variants of Unknown Clinical Significance
Cochran, R. L. (2014)
Urich, A. (2017)
XRCC1, un élément clef de la réparation des dommages de l'ADN couplée à la réplication
Lévy, N. (2007) · OpenGrey (Institut de l'Information Scientifique et Technique)
Brill, S. J. (2004) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.1018112.207612
Zielinski, C. C., Possinger, K., & Kiechle, M. (2004) · Springer eBooks · doi:10.1007/978-3-662-06670-6_43
(2014) · ASM Press eBooks · doi:10.1128/9781555816704.ch6
Managing DNA Strand Breaks in Eukaryotic Cells
Friedberg, E. C., Walker, G. C., Siede, W., Wood, R. D., Schultz, R. A., & Ellenberger, T. (2014) · ASM Press eBooks · doi:10.1128/9781555816704.ch18
Telomeric Regulation in Eukaryotic Cells
Griffith, J. D., & Stansel, R. M. (2003) · CRC Press eBooks · doi:10.1201/9780203911709.ch5
Schwob, É. (2003) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.1013358.190250
Srihari, S., Yong, C. H., & Wong, L. (2017) · doi:10.1145/3064650.3064660
张浩, 方言, 黄翠芬, 杨晓, & 叶棋浓 (2005) · Science in China Series C-Life Sciences (in Chinese) · doi:10.1360/zc2005-35-1-44
Srihari, S., Yong, C. H., & Wong, L. (2017) · doi:10.1145/3064650.3064661
Georgakilas, A. G. (2012) · CRC Press eBooks · doi:10.1201/b14318-7
张浩, 李杰萍, 王晓辉, 孙琰, 袁斌, Yang, Z., Jiang, Y., 曾敏, 丁丽华, 宁康, et al. (2007) · Science in China Series C-Life Sciences (in Chinese) · doi:10.1360/zc2007-37-2-135
Srihari, S., Yong, C. H., & Wong, L. (2017) · doi:10.1145/3064650.3064651
Choi, Y. J., Kim, B., Kim, Y., Shin, S., & Lee, K. (2022) · Laboratory Medicine Online · doi:10.47429/lmo.2022.12.3.145
The MDM2 oncoprotein antagonizes Poly(ADP-ribosyl)ation
Giansanti, C. (2023) · eDiss (Georg-August-Universität Göttingen) · doi:10.53846/goediss-9741
Xu, H., Lu, L., Künert, B., Naredla, R., Applequist, S. E., Grandien, A., & Glas, R. (2023) · doi:10.1158/0008-5472.c.6495987
Xu, H. L., Lu, L., Künert, B., Naredla, R., Applequist, S. E., Grandien, A., & Glas, R. (2023) · doi:10.1158/0008-5472.c.6495987.v1
Telomere, DNA Damage Response, and Nanomedicine: A Triad for Cancer Treatment Innovation
Afshar, Y., Sharif, H., & Rezaei, N. (2024) · Interdisciplinary cancer research · doi:10.1007/16833_2024_486
Pathogenic BRCA1 DBD variants exhibit altered DNA binding affinities and susceptibility to menadionePreprint
Cismas, E., Lowry, E., Salib, V., Lowran, K., & Wu, C. G. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.07.10.664210
Li, X., Jiang, S., Hai-li, L., Li, S., & Hu, Y. (2025) · PLoS ONE · doi:10.1371/journal.pone.0331401
From DNA Replication to Genome Instability in Schizosaccharomyces Pombe: Pathways to Cancer
Bailis, J. M., & Forsburg, S. L. (2007) · Springer eBooks · doi:10.1007/978-1-4020-5963-6_1
Eukaryotic DNA Ligases and DNA Repair
Bowater, R. P. (1998) · Nucleic acids and molecular biology · doi:10.1007/978-3-642-48770-5_13
The role of protein kinases in DNA replication in Saccharomyces cerevisiae
Sweet, S. M. M. (2010) · UCL Discovery (University College London)
Criblage de petites molécules d'intérêt thérapeutique et recherche de leur mécanisme d'action
Rozié, A. (2020) · theses.fr (ABES) · doi:10.70675/cfe93a65zdad1z4f4fzb5e3z4c2daf8ea474
TPI and GAPDH Interact with Rad9, Linking Glycolytic Enzymes to Cancer
Chua, V. X. Y., Yip, J., Cho, M. T. K., Lin, S. Z. Q., Tan, R., Lee, D. G. K., Dai, K., Lim, T. K., Lin, Q., Lehming-Teo, R., et al. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27125327
Das, A., & Ray, S. (2026) · Physiologia Plantarum · doi:10.1111/ppl.71013
Nucleotide Metabolism in Health and Disease
Zhao, X., Zeng, Y., Xu, Y., Rao, S., Khouchani, M., Soummane, H., Li, J., & Liu, R. (2026) · MedComm · doi:10.1002/mco2.70900
Bateman, A. G. (2026) · Bioinformatics Advances · doi:10.1093/bioadv/vbag227
Conservation of the BRCA1 gene
Wronkowski, M. G. (2007) · RIT Scholar Works (Rochester Institute of Technology)
The interaction of CtIP with DNA damage response proteins
Abramowiçz, I. (2010) · University of Birmingham Institutional Research Archive (University of Birmingham)
Prédiction structurale et ingénierie des assemblages macromoléculaires par bioinformatique
Madaoui, H. (2007) · HAL
Polimorfismos nos genes TP53, 53BP1 e ATM: Susceptibilidade para cancro do colo do útero
Oliveira, S. (2011) · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT) · doi:10.34626/6kcb-wz48
Metadata
- Authors
- Bork, P., Hofmann, K., Bucher, P., Neuwald, A. F., Altschul, S. F., & Koonin, E. V.
- Affiliations
- European Molecular Biology Laboratory 69012 Heidelberg Germany
- Swiss Institute for Experimental Cancer Research 1066 Epalinges Switzerland
- National Institutes of Health (US)
- Corresponding author
- Koonin, Eugene V.
- Venue
- The FASEB Journal
- Publisher
- Wiley
- Published
- 1997-01
- Volume
- 11
- Issue
- 1
- Pages
- 68-76
- ISSN
- 0892-6638 (ISSN-L)
- 1530-6860
- OpenAlex
- W1768635289
- Cited by
- 746
- References
- 0
- Citations by year
- 2026: 4 · 2025: 6 · 2024: 4 · 2023: 9 · 2022: 8 · 2021: 11 · 2020: 6 · 2019: 16 · 2018: 5 · 2017: 20 · 2016: 12 · 2015: 23 · 2014: 17 · 2013: 25 · 2012: 22
- FWCI
- 19.32
- Type
- journal article
- Language
- en
- Open access
- green
- infoscience.epfl.ch
- Locations
- The FASEB Journal (publishedVersion)
- PubMed (publishedVersion)
- Infoscience (Ecole Polytechnique Fédérale de Lausanne) (submittedVersion)
- Infoscience (Ecole Polytechnique Fédérale de Lausanne) (submittedVersion, cc-by-nc-nd)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › DNA Repair Mechanisms
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics and Chromatin Dynamics
- Keywords
- BRCT domain, conserved domains, DNA damage response, cell cycle checkpoints, BRCA1, 53BP1, Rad9, Rad4, ECT2, XRCC1, Dpb11, terminal deoxynucleotidyl transferase, DNA ligase III, DNA ligase IV, Rap1, replication factor C, poly(ADP-ribose) polymerase, retinoblastoma protein, transcription activation domain, tandem repeats
- MeSH terms
- Amino Acid Sequence, Animals, Cell Cycle, DNA Damage, Humans, Molecular Sequence Data, Databases, Factual, Sequence Alignment, Conserved Sequence, Sequence Homology, Amino Acid, Sequence Analysis, Cell Cycle Proteins, BRCA1 Protein
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review